NCAPD2
Condensin complex subunit 1
Also known as: CAP-D2, CNAP1, CND1_HUMAN, hCAP-D2, KIAA0159
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15021
- Gene
- NCAPD2
- Ensembl
- ENSG00000010292
- Chromosome
- 12
- Canonical length
- 1401 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Centriolar satellite,Cytosol
OverviewNCBI Gene
Enables histone binding activity. Involved in mitotic chromosome condensation and positive regulation of chromosome condensation. Located in several cellular components, including condensed chromosome; microtubule organizing center; and nuclear lumen. Part of condensin complex. Implicated in primary autosomal recessive microcephaly 21. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1401 residues, UniProt reviewed canonical sequence.
>Q15021|NCAPD2
1 MAPQMYEFHL PLSPEELLKS GGVNQYVVQE VLSIKHLPPQ LRAFQAAFRA QGPLAMLQHF
61 DTIYSILHHF RSIDPGLKED TLQFLIKVVS RHSQELPAIL DDTTLSGSDR NAHLNALKMN
121 CYALIRLLES FETMASQTNL VDLDLGGKGK KARTKAAHGF DWEEERQPIL QLLTQLLQLD
181 IRHLWNHSII EEEFVSLVTG CCYRLLENPT INHQKNRPTR EAITHLLGVA LTRYNHMLSA
241 TVKIIQMLQH FEHLAPVLVA AVSLWATDYG MKSIVGEIVR EIGQKCPQEL SRDPSGTKGF
301 AAFLTELAER VPAILMSSMC ILLDHLDGEN YMMRNAVLAA MAEMVLQVLS GDQLEAAARD
361 TRDQFLDTLQ AHGHDVNSFV RSRVLQLFTR IVQQKALPLT RFQAVVALAV GRLADKSVLV
421 CKNAIQLLAS FLANNPFSCK LSDADLAGPL QKETQKLQEM RAQRRTAAAS AVLDPEEEWE
481 AMLPELKSTL QQLLQLPQGE EEIPEQIANT ETTEDVKGRI YQLLAKASYK KAIILTREAT
541 GHFQESEPFS HIDPEESEET RLLNILGLIF KGPAASTQEK NPRESTGNMV TGQTVCKNKP
601 NMSDPEESRG NDELVKQEML VQYLQDAYSF SRKITEAIGI ISKMMYENTT TVVQEVIEFF
661 VMVFQFGVPQ ALFGVRRMLP LIWSKEPGVR EAVLNAYRQL YLNPKGDSAR AKAQALIQNL
721 SLLLVDASVG TIQCLEEILC EFVQKDELKP AVTQLLWERA TEKVACCPLE RCSSVMLLGM
781 MARGKPEIVG SNLDTLVSIG LDEKFPQDYR LAQQVCHAIA NISDRRKPSL GKRHPPFRLP
841 QEHRLFERLR ETVTKGFVHP DPLWIPFKEV AVTLIYQLAE GPEVICAQIL QGCAKQALEK
901 LEEKRTSQED PKESPAMLPT FLLMNLLSLA GDVALQQLVH LEQAVSGELC RRRVLREEQE
961 HKTKDPKEKN TSSETTMEEE LGLVGATADD TEAELIRGIC EMELLDGKQT LAAFVPLLLK
1021 VCNNPGLYSN PDLSAAASLA LGKFCMISAT FCDSQLRLLF TMLEKSPLPI VRSNLMVATG
1081 DLAIRFPNLV DPWTPHLYAR LRDPAQQVRK TAGLVMTHLI LKDMVKVKGQ VSEMAVLLID
1141 PEPQIAALAK NFFNELSHKG NAIYNLLPDI ISRLSDPELG VEEEPFHTIM KQLLSYITKD
1201 KQTESLVEKL CQRFRTSRTE RQQRDLAYCV SQLPLTERGL RKMLDNFDCF GDKLSDESIF
1261 SAFLSVVGKL RRGAKPEGKA IIDEFEQKLR ACHTRGLDGI KELEIGQAGS QRAPSAKKPS
1321 TGSRYQPLAS TASDNDFVTP EPRRTTRRHP NTQQRASKKK PKVVFSSDES SEEDLSAEMT
1381 EDETPKKTTP ILRASARRHR SLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NCAPD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 72 nTPM
Expression across tissuesHPA
Tissue
- thymus: 72 nTPM
- tonsil: 42 nTPM
- lymph node: 36 nTPM
- bone marrow: 34 nTPM
- skin: 21 nTPM
- appendix: 20 nTPM
Single-cell type
- monocyte progenitors: 159 nCPM
- neutrophil progenitors: 127 nCPM
- erythrocyte progenitors: 108 nCPM
- megakaryocyte progenitors: 78 nCPM
- late spermatids: 53 nCPM
- enteric transient amplifying cells: 43 nCPM
Immune cell
- basophil: 11 nTPM
- T-reg: 8.2 nTPM
- NK-cell: 8.1 nTPM
- naive CD8 T-cell: 7.3 nTPM
- memory CD8 T-cell: 7.2 nTPM
- naive CD4 T-cell: 7.2 nTPM
Brain region
- white matter: 26 nTPM
- medulla oblongata: 22 nTPM
- basal ganglia: 21 nTPM
- thalamus: 19 nTPM
- midbrain: 19 nTPM
- cerebellum: 19 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NCAPD2.
Disease | AllUniProt
Conditions NCAPD2 is implicated in, by any mechanism.
- Microcephaly 21, primary, autosomal recessive (MCPH21) MIM:617983
Disease | GeneticClinVar
9 pathogenic / likely-pathogenic of 331 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Microcephaly 21, primary, autosomal recessive
Disease | ImmuneIEDB
Conditions an epitope on NCAPD2 was assayed in.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.58
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.71
- DepMap mean gene effect
- -1.47
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell division
- meiotic chromosome condensation
- mitotic chromosome condensation
- positive regulation of chromosome condensation
- positive regulation of chromosome segregation
- positive regulation of chromosome separation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Armadillo-like helical
- Armadillo-type fold
- Condensin subunit 1/Condensin-2 complex subunit D3
- Condensin complex subunit 1, C-terminal
- non-SMC mitotic condensation complex subunit 1
- Condensin subunit 1
- Condensin complex subunit 1, N-terminal
- non-SMC mitotic condensation complex subunit 1, N-term
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NCAPD2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NCAPD2 as an antibody target. Whether an autoantibody or antibody against NCAPD2 could matter depends on whether native NCAPD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NCAPD2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NCAPD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...